
INNOVATE (NYSE:VATE) reported higher first-quarter revenue and a narrower loss as growth in its infrastructure business offset weaker results in its Life Sciences and Spectrum segments, management said on the company’s first-quarter 2026 earnings call.
Interim CEO Paul Voigt said the company delivered “a strong start to the year,” citing “solid execution across the portfolio and improving visibility into 2026.” Consolidated revenue for the quarter was $364.8 million, while adjusted EBITDA was $19.7 million.